Cyclometallation of 3-phenyl-6-p-toluidinopyridazine forming a six-membered auracycle and a five-membered palladacycle certified by X-ray analysis
摘要:
3-Phenyl-6-p-toluidinopyridazine (abbreviated as Hptp) was prepared as an ambidentate substrate of cyclometallation. Sodium tetrachloroaurate(III), gold(III) bromide, lithium tetrachloropalladate(II), and rhodium(III) chloride cyclometallated Hptp to give [Au(ptp)Cl-2], [Au(ptp)Br-2] [Pd(ptp)Cl], and [Rh(ptp)(2)Cl], respectively. These complexes and [Pd(ptp)Cl(PBu3)] (PBu3 = tri-n-butylphosphine) were characterized spectroscopically. The square-planar structures of [Au(ptp)Br-2]. (CH3)(2)SO and [Pd(ptp)Cl(PBu3)]. CH3OH were determined by X-ray analysis. Cycloauration preferred forming a six-membered metallacycle while cyclopalladation and cyclorhodation formed five-membered metallacycles. (C) 2001 Published by Elsevier Science Ltd.
Synthesis and biological activity of aminophthalazines and aminopyridazines as novel inhibitors of PGE2 production in cells
摘要:
This Letter reports the synthesis and biological evaluation of a collection of aminophthalazines as a novel class of compounds capable of reducing production of PGE(2) in HCA-7 human adenocarcinoma cells. A total of 28 analogs were synthesized, assayed for PGE2 reduction, and selected active compounds were evaluated for inhibitory activity against COX-2 in a cell free assay. Compound 2xxiv (R-1 = H, R-2 = p-CH3O) exhibited the most potent activity in cells (EC50 = 0.02 mu M) and minimal inhibition of COX-2 activity (3% at 5 mu M). Furthermore, the anti-tumor activity of analog 2vii was analyzed in xenograft mouse models exhibiting good anti-cancer activity. (C) 2012 Elsevier Ltd. All rights reserved.
This Letter reports the synthesis and biological evaluation of a collection of aminophthalazines as a novel class of compounds capable of reducing production of PGE(2) in HCA-7 human adenocarcinoma cells. A total of 28 analogs were synthesized, assayed for PGE2 reduction, and selected active compounds were evaluated for inhibitory activity against COX-2 in a cell free assay. Compound 2xxiv (R-1 = H, R-2 = p-CH3O) exhibited the most potent activity in cells (EC50 = 0.02 mu M) and minimal inhibition of COX-2 activity (3% at 5 mu M). Furthermore, the anti-tumor activity of analog 2vii was analyzed in xenograft mouse models exhibiting good anti-cancer activity. (C) 2012 Elsevier Ltd. All rights reserved.
Cyclometallation of 3-phenyl-6-p-toluidinopyridazine forming a six-membered auracycle and a five-membered palladacycle certified by X-ray analysis
3-Phenyl-6-p-toluidinopyridazine (abbreviated as Hptp) was prepared as an ambidentate substrate of cyclometallation. Sodium tetrachloroaurate(III), gold(III) bromide, lithium tetrachloropalladate(II), and rhodium(III) chloride cyclometallated Hptp to give [Au(ptp)Cl-2], [Au(ptp)Br-2] [Pd(ptp)Cl], and [Rh(ptp)(2)Cl], respectively. These complexes and [Pd(ptp)Cl(PBu3)] (PBu3 = tri-n-butylphosphine) were characterized spectroscopically. The square-planar structures of [Au(ptp)Br-2]. (CH3)(2)SO and [Pd(ptp)Cl(PBu3)]. CH3OH were determined by X-ray analysis. Cycloauration preferred forming a six-membered metallacycle while cyclopalladation and cyclorhodation formed five-membered metallacycles. (C) 2001 Published by Elsevier Science Ltd.